A PASSION FOR PHARMACEUTICALS

Download A passion for pharmaceuticals. The pressure to innovate and to bring to the market groundbreaking new drugs and treat- ments for all kinds ...

0 downloads 596 Views 2MB Size
Interview with Lamberto Pedrotti, Managing Director, and Stefano Dessena, International Director of Laboratorio Farmaceutico S.I.T. s.r.l.

A passion for pharmaceuticals The pressure to innovate and to bring to the market groundbreaking new drugs and treatments for all kinds of illnesses and diseases has resulted in a constantly accelerating spiral that even large pharmaceutical companies have to face. As a result of ongoing diversification, mergers and acquisitions, pharmaceutical companies or parts of their portfolio are for sale. This is where Laboratorio Farmaceutico S.I.T. s.r.l. comes in. The family company focuses on branded, off-patent pharmaceuticals and markets them in Europe and beyond.

considered the core of a manufac-

Mr. Pedrotti. “In the same year,

turer’s portfolio. Since the 1970s,

we set up Desma Healthcare at

the company has helped many

the head of our group, which

products start a second life cycle

focuses on the two major objec-

through brand acquisition and the

tives of acquiring well-established

takeover of formulations with listed

brands and strengthening its Eu-

registration dossier, including all

ropean network and expanding in

the relevant details on a drug’s

new potential markets.” “Desma

origin.

Healthcare has been established as our reference brand, with of-

International Director Stefano Dessena (left) and Managing Director Lamberto Pedrotti stress the company’s focus on branded, off-patent pharmaceuticals

From 2000 on, Laboratorio Farma-

fices in Germany and France and

ceutico S.I.T. has bought mature

another representative in Chiasso,

products, both in Italy and abroad,

Switzerland, while all other mar-

which can be seen as a decisive

kets are organized directly through

milestone in the company’s de-

our Italian headquarters,” says

velopment, as it opened the doors to the acquired products’ original

“We have always worked hard to

when they set up Laboratorio Far-

markets. “The next logical step

excel in the pharmaceutical busi-

maceutico S.I.T. in 1930, driven by

was the opening of new subsidiar-

ness by acquiring manufacturing,

the desire to develop pharmaceuti-

ies in Spain and Germany,” says

sales and distribution rights to

cal products. Following initial de-

off-patent brand products from

velopment, production was the

major pharmaceutical companies,”

second step in expanding the

points out Lamberto Pedrotti,

small company in the 1930s.

Managing Director and member of the Devalle-Pedrotti family,

Over the years, the company

which owns 40% of the company’s

shifted its focus from develop-

shares. Mr. Pedrotti worked as a

ment and production to the

lawyer before joining the family

acquisition and marketing of well-

company in 2009. The company’s

established brands and off-patent

founders were all keen chemists

products that no longer were

Centellase is a blood vessel protector

Laboratorio Farmaceutico S.I.T. s.r.l. Via Cavour 70 27035 Mede (PV) Italy

 +39 0384 8071  +39 0384 822133  [email protected]  www.sit-farmaceutici.com

The headquarters of Laboratorio Farmaceutico S.I.T. in Mede

International Director Stefano Des-

Vietnam. “We are about to conquer

various therapeutic categories.

well-known remedy for all kinds of

sena, who has been working in

the South American market. We

For instance, we supply Akineton,

injuries.

this position since January 2015.

used to be quite active there, but

a product developed for the cen-

“I was very much intrigued by the

our business partners ceased to

tral nervous system, and Kalinor,

In 2015, Laboratorio Farmaceutico

company’s portfolio and business

develop and expand our market

which prevents and treats kidney

S.I.T. ranked among the top 504

approach. I had been working for

potential. We flew in ourselves and

stones,” explains Mr. Pedrotti.

in the pharmaceutical produc-

another Big Pharma company, but

had very constructive talks with lo-

“Kalinor is a highly complex prod-

tion market. This might not be an

following a conversation with Mr.

cal distributors,” says Mr. Dessena.

uct which is hard to copy and

impressive position with regard to

Pedrotti about the aspects of my

“I think it is always important to

reproduce – probably the most

large multinationals, but the com-

work as a new ‘worldwide man-

set up close personal bonds. You

sold product worldwide, generat-

pany operates a sound internation-

ager’, I was definitely won over.

cannot just sit in your office and

ing a turnover of 17 million EUR.”

al structure and strongly focuses

This was the beginning of a very

expect everything to run smoothly,

The same is true for Akineton,

on its international presence, an

interesting new prospect in my

but instead you travel and see

which is among the company’s

important asset in this competitive

working life.”

the local situation yourself.” The

more than 85 pharmaceutical

market. “In the coming years, we

company’s vast portfolio includes

products. It is applied as an anti-

aim to increase our international

Today, Laboratorio Farmaceutico

pharmaceuticals, nutritional sup-

Parkinson’s agent, which is hard

expansion in order to compensate

S.I.T.’s products are manufactured

plements, medical devices and

to replace. “We recommend that

for any stagnation in our home

at the company’s two produc-

surgical medical products, cover-

any medical doctor should carry it,

market,” says Mr. Pedrotti. “We

tion sites in Mede near Pavia and

ing the treatment areas breathing

as it can even help save lives.” In

are about to launch two new prod-

Tavernerio near Como. Its pharma-

apparatus, disinfection, gastro-

addition, the portfolio boasts many

ucts right now for areas where

ceutical products are distributed

enterology, vein insufficiency and

OTC medications, like Centel-

there has been no medication so

as far as Taiwan, Thailand and

neurology. “We offer solutions for

lase and Trofodermin, the latter a

far. It is still very secret.”

Akineton is used as an anti-Parkinson’s agent

Centellase is available as a pill or ointment

Kalinor prevents and treats kidney stones